Multiple Sclerosis

MD IQ

From the Journals

BTK inhibitor reduces MS enhancing lesions

However, neither the 75-mg nor 25-mg dosing regimens significantly reduced Expanded Disability Status Scale scores, compared with placebo.

Conference Coverage

The art of selecting an MS therapy

DALLAS – Clinical and imaging findings may indicate disease phase, severity, and prognosis, which can inform the treatment choice.

Pages